Literature DB >> 33619628

Vitamin B12 may play a preventive role in esophageal precancerous lesions: a case-control study based on markers in blood and 3-day duplicate diet samples.

Da Pan1, Shaokang Wang2, Ming Su3, Guiju Sun1, Xiaopan Zhu1, Mahsa Ghahvechi Chaeipeima1, Ziqi Guo1, Niannian Wang1, Ziyu Zhang1, Mengjing Cui1.   

Abstract

PURPOSE: It is hypothesized that vitamin B12 may prevent tumor initiation during the early stage of carcinogenesis such as esophageal precancerous lesions (EPL), whereas an excessive level may promote tumor progression during the later stages of carcinogenesis. This study aimed to determine the role of vitamin B12 in EPL by detecting vitamin B12-related markers in both blood and diet.
METHODS: This case-control study based on 3-day duplicated diet samples was conducted in a high-risk area of Huai'an, China. A 100 EPL cases and 100 healthy controls matched by gender, age (± 2 years) and villages were included. Dietary intake of vitamin B12 and cobalt, plasma cobalt level, the serum levels of vitamin B12 and transcobalamin II (TC II) were quantitatively analyzed.
RESULTS: Dietary vitamin B12 intake (p for trend = 0.384) and plasma cobalt level (p for trend = 0.253) were not associated with EPL risk, but high dietary cobalt intake (p for trend = 0.034), increased serum levels of vitamin B12 (p for trend = 0.036) and TC II (p for trend < 0.001) were significantly associated with the reduced EPL risk. However, the significant negative association between dietary cobalt intake, plasma cobalt level or serum vitamin B12 level and EPL was only found in female or male subjects.
CONCLUSION: Excellent transport capability of bio-active vitamin B12 in vivo and adequate levels of vitamin B12 and cobalt may play preventive roles in EPL. Additionally, the association between vitamin B12, cobalt and the risk of EPL may vary in different genders.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Cobalt; Duplicate diet; Esophageal precancerous lesions; Transcobalamin II; Vitamin B12

Mesh:

Substances:

Year:  2021        PMID: 33619628     DOI: 10.1007/s00394-021-02516-0

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  27 in total

Review 1.  Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.

Authors:  Simon M Collin; Chris Metcalfe; Helga Refsum; Sarah J Lewis; Luisa Zuccolo; George Davey Smith; Lina Chen; Ross Harris; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Marta Ebbing; Kaare Harald Bønaa; Ottar Nygård; Per Magne Ueland; Maria V Grau; John A Baron; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Esophageal carcinoma.

Authors:  Anil K Rustgi; Hashem B El-Serag
Journal:  N Engl J Med       Date:  2014-12-25       Impact factor: 91.245

Review 3.  Epidemiology of Esophageal Squamous Cell Carcinoma.

Authors:  Christian C Abnet; Melina Arnold; Wen-Qiang Wei
Journal:  Gastroenterology       Date:  2017-08-18       Impact factor: 22.682

4.  Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.

Authors:  M Matejcic; J de Batlle; C Ricci; C Biessy; F Perrier; I Huybrechts; E Weiderpass; M C Boutron-Ruault; C Cadeau; M His; D G Cox; H Boeing; R T Fortner; R Kaaks; P Lagiou; A Trichopoulou; V Benetou; R Tumino; S Panico; S Sieri; D Palli; F Ricceri; H B As Bueno-de-Mesquita; G Skeie; P Amiano; M J Sánchez; M D Chirlaque; A Barricarte; J R Quirós; G Buckland; C H van Gils; P H Peeters; T J Key; E Riboli; B Gylling; A Zeleniuch-Jacquotte; M J Gunter; I Romieu; V Chajès
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

5.  Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

Authors:  Johan Hultdin; Bethany Van Guelpen; Anders Bergh; Göran Hallmans; Pär Stattin
Journal:  Int J Cancer       Date:  2005-02-20       Impact factor: 7.396

6.  Elevated Vitamin B12 Levels and Cancer Risk in UK Primary Care: A THIN Database Cohort Study.

Authors:  Johan F H Arendt; Henrik T Sørensen; Laura J Horsfall; Irene Petersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-14       Impact factor: 4.254

7.  Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort.

Authors:  Stefan de Vogel; Klaus Meyer; Åse Fredriksen; Arve Ulvik; Per Magne Ueland; Ottar Nygård; Stein Emil Vollset; Grethe S Tell; Steinar Tretli; Tone Bjørge
Journal:  Int J Epidemiol       Date:  2013-02       Impact factor: 7.196

8.  Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study.

Authors:  Q Xiao; N D Freedman; J Ren; A R Hollenbeck; C C Abnet; Y Park
Journal:  Br J Cancer       Date:  2014-01-30       Impact factor: 7.640

9.  Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.

Authors:  Alison J Price; Ruth C Travis; Paul N Appleby; Demetrius Albanes; Aurelio Barricarte Gurrea; Tone Bjørge; H Bas Bueno-de-Mesquita; Chu Chen; Jenny Donovan; Randi Gislefoss; Gary Goodman; Marc Gunter; Freddie C Hamdy; Mattias Johansson; Irena B King; Tilman Kühn; Satu Männistö; Richard M Martin; Klaus Meyer; David E Neal; Marian L Neuhouser; Ottar Nygård; Par Stattin; Grethe S Tell; Antonia Trichopoulou; Rosario Tumino; Per Magne Ueland; Arve Ulvik; Stefan de Vogel; Stein Emil Vollset; Stephanie J Weinstein; Timothy J Key; Naomi E Allen
Journal:  Eur Urol       Date:  2016-04-06       Impact factor: 20.096

10.  MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study.

Authors:  Da Pan; Ming Su; Guiling Huang; Pengfei Luo; Ting Zhang; Lingmeng Fu; Jie Wei; Shaokang Wang; Guiju Sun
Journal:  Cancer Cell Int       Date:  2019-11-12       Impact factor: 5.722

View more
  2 in total

1.  Trends in Incidence and Mortality of Esophageal Cancer in Huai'an District, a High-Risk Area in Northern Jiangsu Province, China.

Authors:  Shaokang Wang; Da Pan; Zitong Chen; Guang Song; Renqiang Han; Guiju Sun; Ming Su
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

2.  Inverse relations between Helicobacter pylori infection and risk of esophageal precancerous lesions in drinkers and peanut consumption.

Authors:  Da Pan; Gui-Ju Sun; Ming Su; Xin Wang; Qing-Yang Yan; Guang Song; Yuan-Yuan Wang; Deng-Feng Xu; Nian-Nian Wang; Shao-Kang Wang
Journal:  World J Gastrointest Oncol       Date:  2022-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.